These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7747464)

  • 41. Mutations in both env and gag genes are required for HIV-1 resistance to the polysulfonic dendrimer SPL2923, as corroborated by chimeric virus technology.
    Hantson A; Fikkert V; Van Remoortel B; Pannecouque C; Cherepanov P; Matthews B; Holan G; De Clercq E; Vandamme AM; Debyser Z; Witvrouw M
    Antivir Chem Chemother; 2005; 16(4):253-66. PubMed ID: 16130523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low number of functionally active B lymphocytes in the peripheral blood of HIV-1-seropositive individuals with low p24-specific serum antibody titers.
    Teeuwsen VJ; Lange JM; Keet R; Schattenkerk JK; Debouck C; van den Akker R; Goudsmit J; Osterhaus AD
    AIDS; 1991 Aug; 5(8):971-9. PubMed ID: 1723280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal analysis of HIV-1-specific antibody responses.
    Curtis KA; Kennedy MS; Owen SM
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1099-105. PubMed ID: 25314631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biological characterization of noninfectious HIV-1 particles lacking the envelope protein.
    Sadaie MR; Kalyanaraman VS; Mukopadhayaya R; Tschachler E; Gallo RC; Wong-Staal F
    Virology; 1992 Apr; 187(2):604-11. PubMed ID: 1546456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice.
    Kawamura M; Naito T; Ueno M; Akagi T; Hiraishi K; Takai I; Makino M; Serizawa T; Sugimura K; Akashi M; Baba M
    J Med Virol; 2002 Mar; 66(3):291-8. PubMed ID: 11793379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new method for induction of specific polyclonal antibodies using immunostained proteins on nitrocellulose membrane, and HIV 1 core antigen and Escherichia coli verotoxin as examples.
    Sandkamp O; Karch H; Laufs R
    FEMS Microbiol Immunol; 1988 Jul; 1(2):109-14. PubMed ID: 2483676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma.
    Zhang C; Chen Y; Ben K
    BMC Infect Dis; 2003 Dec; 3():30. PubMed ID: 14693038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single point dilution method for the quantitative analysis of antibodies to the gag24 protein of HIV-1.
    Palenzuela DO; Benítez J; Rivero J; Serrano R; Ganzó O
    J Immunol Methods; 1997 Oct; 208(1):43-8. PubMed ID: 9433459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs.
    Francica JR; Zak DE; Linde C; Siena E; Johnson C; Juraska M; Yates NL; Gunn B; De Gregorio E; Flynn BJ; Valiante NM; Malyala P; Barnett SW; Sarkar P; Singh M; Jain S; Ackerman M; Alam M; Ferrari G; Salazar A; Tomaras GD; O'Hagan DT; Aderem A; Alter G; Seder RA
    Blood Adv; 2017 Nov; 1(25):2329-2342. PubMed ID: 29296883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA.
    Herzner AM; Hagmann CA; Goldeck M; Wolter S; Kübler K; Wittmann S; Gramberg T; Andreeva L; Hopfner KP; Mertens C; Zillinger T; Jin T; Xiao TS; Bartok E; Coch C; Ackermann D; Hornung V; Ludwig J; Barchet W; Hartmann G; Schlee M
    Nat Immunol; 2015 Oct; 16(10):1025-33. PubMed ID: 26343537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Photoinduced Photosensitizer-Antibody Conjugates Kill HIV Env-Expressing Cells, Also Inactivating HIV.
    Sadraeian M; da Cruz EF; Boyle RW; Bahou C; Chudasama V; Janini LMR; Diaz RS; Guimarães FEG
    ACS Omega; 2021 Jun; 6(25):16524-16534. PubMed ID: 34235324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reaction (dpol,2He) at intermediate energies.
    Ellegaard C; Gaarde C; Jorgensen TS; Larsen JS; Goodman C; Bergqvist I; Brockstedt A; Ekström P; Bedjidian M; Contardo D; Grossiord JY; Guichard A; Bachelier D; Boyard JL; Hennino T; Jourdain JC; Roy-Stephan M; Radvanyi P; Tinsley J
    Phys Rev Lett; 1987 Aug; 59(9):974-977. PubMed ID: 10035926
    [No Abstract]   [Full Text] [Related]  

  • 53. A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination.
    Crosby CM; Weaver EA; Khare R; Barry MA
    Virol Rep; 2015 Dec; 5():47-55. PubMed ID: 26550557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA Immunization for HIV Vaccine Development.
    Chen Y; Wang S; Lu S
    Vaccines (Basel); 2014 Feb; 2(1):138-59. PubMed ID: 26344472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA immunization.
    Wang S; Lu S
    Curr Protoc Microbiol; 2013 Nov; 31():18.3.1-18.3.24. PubMed ID: 24510291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates.
    Chakrabarti BK; Feng Y; Sharma SK; McKee K; Karlsson Hedestam GB; Labranche CC; Montefiori DC; Mascola JR; Wyatt RT
    J Virol; 2013 Dec; 87(24):13239-51. PubMed ID: 24067980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1).
    Wallace A; West K; Rothman AL; Ennis FA; Lu S; Wang S
    Hum Vaccin Immunother; 2013 Oct; 9(10):2095-102. PubMed ID: 23941868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine.
    Yan J; Corbitt N; Pankhong P; Shin T; Khan A; Sardesai NY; Weiner DB
    Vaccine; 2011 Sep; 29(41):7173-81. PubMed ID: 21651948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines.
    Weaver EA; Nehete PN; Nehete BP; Buchl SJ; Palmer D; Montefiori DC; Ng P; Sastry KJ; Barry MA
    Viruses; 2009 Dec; 1(3):920. PubMed ID: 20107521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes.
    Abdel-Motal UM; Wang S; Awad A; Lu S; Wigglesworth K; Galili U
    Vaccine; 2010 Feb; 28(7):1758-65. PubMed ID: 20034607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.